Finally, medications like denosumab, which is a monoclonal antibody that inhibits osteoclasts, and raloxifene, which is a selective estrogen receptor modulator, can be used for postmenopausal osteoporosis.

最后，地诺单抗等药物作为单克隆抗体可抑制破骨细胞；雷洛昔芬，一种有选择性的雌激素受体调节器，可以被用于绝经后骨质疏松。